
    
      It is an open clinical trial. Among the patients who received autologous cartilage cell graft
      using CHONDRON (autologous cartilage cells) in the past (investigational group) or
      microfracture (control group), the subjects who agreed to participate in the trial
      voluntarily will undergo the screening process that assesses the suitability of the subjects
      to the clinical trial and participate in the clinical trial. During the clinical trial
      period, the subjects should follow the instruction of clinician in charge. Hospital visit is
      total 2 times* regularly. At the visit, to evaluate the efficacy according to the protocol,
      the subject will be examined by clinicians, MRI test, and X-ray. If the selection time and
      the visit time are same, hospital visit will be one time*.
    
  